Table 2:
Summary of reported funders of clinical practice guidelines and organizational guideline producers
| Guideline producer | Funder of guideline* | Funder of guideline producer | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
| As reported in guideline | As reported in guideline | Drug industry funding as reported on producer website | |||||||||
|
|
|
||||||||||
| Producer | Government | Non-profit | Drug industry | None reported | Government | Non-profit | Drug industry | Other | None reported | ||
| Government-sponsored organizations (n = 3) | – | 3 | – | – | – | 2 | – | – | – | 1 | Yes = 0 No = 3 Not reported = 0 |
|
| |||||||||||
| Disease or condition interest groups (n = 9) | 5 | 2 | 1 | – | 3 | 1 | – | – | – | 8 | Yes = 6 No = 1 Not reported = 2 |
|
| |||||||||||
| Medical professional societies (n = 9) | 3 | 1 | 1 | 1 | 6 | – | – | – | – | 9 | Yes = 8 No = 0 Not reported = 1 |
|
| |||||||||||
| Total | 8 | 6 | 2 | 1 | 9 | 3 | 0 | 0 | 0 | 18 | Yes = 14 No = 4 Not reported = 3 |
*
Sum of values in final row of this section (26) is greater than the number of guideline producers (21) because there were multiple funding sources for some of the guidelines.